Chimeric antigens displaying GPR65 extracellular loops on a soluble scaffold enabled the discovery of antibodies, which recognized native receptor.
Janine BarrettSeppe LeysenCécile GalmicheHussein Al-MossawiPaul BownessThomas E EdwardsAlastair D G LawsonPublished in: Bioengineered (2024)
GPR65 is a proton-sensing G-protein coupled receptor associated with multiple immune-mediated inflammatory diseases, whose function is relatively poorly understood. With few reagents commercially available to probe the biology of receptor, generation of an anti-GPR65 monoclonal antibody was desired. Using soluble chimeric scaffolds, such as ApoE3, displaying the extracellular loops of GPR65, together with established phage display technology, native GPR65 loop-specific antibodies were identified. Phage-derived loop-binding antibodies recognized the wild-type native receptor to which they had not previously been exposed, generating confidence in the use of chimeric soluble proteins to act as efficient surrogates for membrane protein extracellular loop antigens. This technique provides promise for the rational design of chimeric antigens in facilitating the discovery of specific antibodies to GPCRs.
Keyphrases
- cell therapy
- fatty acid
- monoclonal antibody
- wild type
- small molecule
- dendritic cells
- transcription factor
- pseudomonas aeruginosa
- binding protein
- high throughput
- oxidative stress
- mesenchymal stem cells
- machine learning
- type diabetes
- skeletal muscle
- high fat diet
- insulin resistance
- quantum dots
- immune response
- living cells
- cystic fibrosis
- deep learning
- dna binding